Delayed Quote. Delayed  - 03/04 04:10:00 pm
115.27USD -2.27%

Medtronic : Starts Adaptive Deep Brain Stimulation Trial in Parkinson's Disease Patients

01/14/2021 | 10:24am
(MT Newswires) -- Medtronic (MDT) said on Thursday it has started a trial evaluating the safety and efficacy of adaptive deep brain stimulation in patients with Parkinson's disease.

The medical technology company said the study will allow for automated adjustment of brain stimulation to provide therapy to manage symptoms of Parkinson's disease. It said adaptive deep brain stimulation is an investigational feature of its Percept PC device that could be enabled if approved.

Price: 118.42, Change: -0.30, Percent Change: -0.25

© MT Newswires 2021
Copier lien
All news about MEDTRONIC PLC
20h ago
22h ago
23h ago
1d ago
2d ago